Advertisement

Out-of-Pocket Spending for Asthma-Related Care Among Commercially Insured Patients, 2004-2016

Published:August 31, 2021DOI:https://doi.org/10.1016/j.jaip.2021.07.054

      Background

      Out-of-pocket (OOP) health care costs can cause financial burden and deferred care for many Americans. Little is known about OOP spending for asthma-related care among the commercially insured.

      Objectives

      To analyze OOP spending for asthma-related care overall, across types of care, and by income.

      Methods

      Using enrollment, claims, and geocoded census tract data on income from a large US commercial health plan from 2004 to 2016, we measured inflation-adjusted OOP spending for individuals with asthma ages 4 to 64 years (n = 1,986,769). We estimated annual asthma-related OOP spending over time, and average total, asthma-related, asthma type of care, and asthma medication spending by income. We measured trends in median OOP cost per medication. Linear regression models were adjusted for patient covariates and deductible level.

      Results

      Asthma-related OOP spending decreased over time both for patients enrolled in high-deductible health plans and for those in traditional plans. High-deductible plan enrollment increased from 7% to 54%. Compared with patients living in high-income areas, patients in the lowest-income areas had similar annual total and asthma-related OOP spending, but spent 30% less on controller medications and a higher proportion of their asthma-related OOP spending on inpatient and emergency care (10% vs 3%; P < .001). Asthma-related OOP spending represented a higher proportion of household income for patients in lower-income areas.

      Conclusions

      Patients with asthma living in the lowest-income areas have greater cost burden, lower spending on controller medications, and greater spending on high-acuity care than higher-income counterparts.

      Key words

      Abbreviations used:

      ACG (Adjusted Clinical Group), HDHP (High-deductible health plan), ICD-9 (International Classification of Diseases, Ninth Revision), ICE (Index of Concentration at Extremes), ICS (Inhaled corticosteroid), ICS-LABA (ICS-long-acting β-agonist), OOP (Out-of-pocket)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to The Journal of Allergy and Clinical Immunology: In Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nurmagambetov T.
        • Kuwahara R.
        • Garbe P.
        The economic burden of asthma in the United States, 2008–2013.
        Ann Am Thorac Soc. 2018; 15: 348-356
        • Goldman D.P.
        • Joyce G.F.
        • Escarce J.J.
        • Pace J.E.
        • Solomon M.D.
        • Laouri M.
        • et al.
        Pharmacy benefits and the use of drugs by the chronically ill.
        J Am Med Assoc. 2004; 291: 2344-2350
        • Blais L.
        • Couture J.
        • Rahme E.
        • LeLorier J.
        Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance.
        Health Policy (New York). 2003; 64: 163-172
        • Campbell J.D.
        • Allen-Ramey F.
        • Sajjan S.G.
        • Maiese E.M.
        • Sullivan S.D.
        Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
        Am J Manag Care. 2011; 17: 703-710
        • Karaca-Mandic P.
        • Jena A.B.
        • Joyce G.F.
        • Goldman D.P.
        Out-of-pocket medication costs and use of medications and health care services among children with asthma.
        JAMA. 2012; 307: 1284-1291
        • Ungar W.J.
        • Paterson J.M.
        • Gomes T.
        • Bikangaga P.
        • Gold M.
        • To T.
        • et al.
        Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma.
        Ann Allergy Asthma Immunol. 2011; 106: 17-23
        • Galbraith A.A.
        • Ross-Degnan D.
        • Zhang F.
        • Wu A.C.
        • Sinaiko A.
        • LeCates R.F.
        • et al.
        Association of controller use and exacerbations for high-deductible plan enrollees with and without family members with asthma.
        Ann Am Thorac Soc. 2021; 18: 1255-1260
        • Miller G.E.
        • Vistnes J.P.
        • Rohde F.
        • Keenan P.S.
        High-deductible health plan enrollment increased from 2006 to 2016, employer-funded accounts grew in largest firms.
        Health Aff. 2018; 37: 1231-1237
        • Aaron M.B.
        • Sinaiko A.D.
        Spending and out-of-pocket prices for brand-name drugs among commercially insured individuals in Massachusetts, 2015-2017.
        JAMA Netw Open. 2021; 4: 2015-2017
        • Gelhorn H.L.
        • Balantac Z.
        • Ambrose C.S.
        • Chung Y.N.
        • Stone B.
        Patient and physician preferences for attributes of biologic medications for severe asthma.
        Patient Prefer Adherence. 2019; 13: 1253-1268
        • Hanania N.A.
        • Hawken N.
        • Gilbert I.
        • Martinez F.J.
        • Fox K.M.
        • Ross M.M.
        • et al.
        What symptomatic patients with asthma and chronic obstructive pulmonary disease (COPD) find important in their maintenance inhaler therapy: a focus group study.
        Am J Respir Crit Care Med. 2018; 197: A4863
        • Segel J.E.
        • Kullgren J.T.
        Health insurance deductibles and their associations with out-of-pocket spending and affordability barriers among US adults with chronic conditions.
        JAMA Intern Med. 2017; 177: 433
        • Carrier E.
        • Cunningham P.
        Medical cost burdens among nonelderly adults with asthma.
        Am J Manag Care. 2014; 20: 8
        • Inselman J.W.
        • Jeffery M.M.
        • Maddux J.T.
        • Shah N.D.
        • Rank M.A.
        Trends and disparities in asthma biologic use in the United States.
        J Allergy Clin Immunol Pract. 2020; 8: 549-554.e1
        • Fung V.
        • Graetz I.
        • Galbraith A.
        • Hamity C.
        • Huang J.
        • Vollmer W.M.
        • et al.
        Financial barriers to care among low-income children with asthma: health care reform implications.
        JAMA Pediatr. 2014; 168: 649-656
        • Wang T.
        • Srebotnjak T.
        • Brownell J.
        • Hsia R.Y.
        Emergency department charges for asthma-related outpatient visits by insurance status.
        J Health Care Poor Underserved. 2014; 25: 396-405
        • Ivanova J.I.
        • Bergman R.
        • Birnbaum H.G.
        • Colice G.L.
        • Silverman R.A.
        • McLaurin K.
        Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma.
        J Allergy Clin Immunol. 2012; 129: 1229-1235
        • Galbraith A.A.
        • Fung V.
        • Li L.
        • Butler M.G.
        • Nordin J.D.
        • Hsu J.
        • et al.
        Impact of copayment changes on children’s albuterol inhaler use and costs after the Clean Air Act chlorofluorocarbon ban.
        Health Serv Res. 2018; 53: 156-174
        • Tse S.M.
        • Li L.
        • Butler M.G.
        • Fung V.
        • Kharbanda E.O.
        • Larkin E.K.
        • et al.
        Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use.
        Am J Respir Crit Care Med. 2013; 188: 1076-1082
        • U.S. Bureau of Labor Statistics
        Consumer Price Index for all urban consumers: medical care in U.S. city average [CPIMEDSL].
        (Available from:) (Accessed March 8, 2021)
        • Wharam J.F.
        • Zhang F.
        • Wallace J.
        • Lu C.
        • Earle C.
        • Soumerai S.B.
        • et al.
        Vulnerable and less vulnerable women in high-deductible health plans experienced delayed breast cancer care.
        Health Aff. 2019; 38: 408-415
        • The Johns Hopkins ACG System Version 11
        1 Technical Reference Guide.
        Johns Hopkins University, Baltimore, MD2016
        • Wharam J.F.
        • Zhang F.
        • Eggleston E.M.
        • Lu C.Y.
        • Soumerai S.
        • Ross-Degnan D.
        Diabetes outpatient care and acute complications before and after high-deductible insurance enrollment: a natural experiment for translation in diabetes (NEXT-D) study.
        JAMA Intern Med. 2017; 177: 358-368
        • Krieger N.
        • Waterman P.D.
        • Spasojevic J.
        • Li W.
        • Maduro G.
        • Van Wye G.
        Public health monitoring of privilege and deprivation with the index of concentration at the extremes.
        Am J Public Health. 2016; 106: 256-263
        • US Census Bureau
        American Community Survey (ACS).
        US Census Bureau, Suitland-Silver Hill, MD2021
        • US Department of Agriculture Economic Research Service
        Rural-urban continuum codes. 2020.
        (Available from:) (Accessed April 15, 2021)
        • Buntin M.B.
        • Zaslavsky A.M.
        Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures.
        J Health Econ. 2004; 23: 525-542
        • US Food and Drug Administration
        Transition from CFC propelled albuterol inhalers to HFA propelled albuterol inhalers: questions and answers.
        Food & Drug Administration, Silver Spring, MD2018

      References

        • US Census Bureau
        American Community Survey (ACS).
        (Available from:) (Accessed July 31, 2020)
        • US Census Bureau
        When to use 1-year, 3-year, or 5-year estimates.
        (Accessed July 31, 2020)
        • US Department of Agriculture, Economic Research Service
        Rural-urban continuum codes.
        (Available from:) (Accessed April 15, 2021)